THE ASSOCIATION BETWEEN ALUMINUM-CONTAINING PRODUCTS AND ALZHEIMERS-DISEASE

被引:102
作者
GRAVES, AB
WHITE, E
KOEPSELL, TD
REIFLER, BV
VANBELLE, G
LARSON, EB
机构
[1] BATTELLE MEM INST,SEATTLE RES CTR,SEATTLE,WA 98105
[2] UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195
[3] UNIV WASHINGTON,DEPT EPIDEMIOL & HLTH SERV,SEATTLE,WA 98195
[4] UNIV WASHINGTON,DEPT BIOSTAT,SEATTLE,WA 98195
[5] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
[6] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,WINSTON SALEM,NC 27103
关键词
Aluminum; Alzheimer's disease; Epidemiology;
D O I
10.1016/0895-4356(90)90053-R
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The association between exposure to aluminum through the lifetime use of antiperspirants and antacids and Alzheimer's disease (AD) was explored in a case-control study of 130 matched pairs. Cases were clinically diagnosed between January 1980 and June 1985 at two geriatric psychiatric clinics in Seattle, Wash. Controls were friends or non-blood relatives of the case. Subjects were matched by age, sex, and the relationship between the case and his or her surrogate. For all antiperspirant/deodorant use, regardless of aluminum content, there was no association with AD (adjusted odds ratio (OR) = 1.2, 95% CI= 0.6-2.4). For aluminum-containing antiperspirants, the overall adjusted OR was 1.6 (95% CI = 1.04-2.4) with a trend toward a higher risk with increasing frequency of use (p for trend = 0.03), the adjusted OR in the highest tertile being 3.2. For antacids regardless of aluminum content, the overall adjusted OR was 3.1 (95% CI= 1.2-7.9). Here, a steep dose-response gradient was found (p for trend = 0.009), with an adjusted OR for the highest tertile of 11.7. However, when only aluminum-containing antacids were analyzed, the overall adjusted OR was only 0.7 (95% CI = 0.3-2.0) and there was no significant dose-response trend. These results are provocative but inconclusive due to methodologic problems relating to the necessary use of surrogate respondents and the long time period of potential exposure for this dementing disease. © 1990.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 42 条
  • [1] DIALYSIS ENCEPHALOPATHY SYNDROME - POSSIBLE ALUMINUM INTOXICATION
    ALFREY, AC
    LEGENDRE, GR
    KAEHNY, WD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (04) : 184 - 188
  • [2] RISK-FACTORS FOR CLINICALLY DIAGNOSED ALZHEIMERS-DISEASE - A CASE-CONTROL STUDY OF AN ITALIAN POPULATION
    AMADUCCI, LA
    FRATIGLIONI, L
    ROCCA, WA
    FIESCHI, C
    LIVREA, P
    PEDONE, D
    BRACCO, L
    LIPPI, A
    GANDOLFO, C
    BINO, G
    PRENCIPE, M
    BONATTI, ML
    GIROTTI, F
    CARELLA, F
    TAVOLATO, B
    FERLA, S
    LENZI, GL
    CAROLEI, A
    GAMBI, A
    GRIGOLETTO, F
    SCHOENBERG, BS
    [J]. NEUROLOGY, 1986, 36 (07) : 922 - 931
  • [3] Breslow N, 1980, STATISTICAL METHODS, V32
  • [4] CANDY JM, 1986, LANCET, V1, P354
  • [5] ALUMINUM, NEUROFIBRILLARY DEGENERATION AND ALZHEIMERS DISEASE
    CRAPPER, DR
    KRISHNAN, SS
    QUITTKAT, S
    [J]. BRAIN, 1976, 99 (MAR) : 67 - 80
  • [6] BRAIN ALUMINUM DISTRIBUTION IN ALZHEIMERS DISEASE AND EXPERIMENTAL NEUROFIBRILLARY DEGENERATION
    CRAPPER, DR
    KRISHNAN, SS
    DALTON, AJ
    [J]. SCIENCE, 1973, 180 (4085) : 511 - 513
  • [7] ALTERATIONS IN SHORT-TERM RETENTION, CONDITIONED AVOIDANCE RESPONSE ACQUISITION AND MOTIVATION FOLLOWING ALUMINUM INDUCED NEUROFIBRILLARY DEGENERATION
    CRAPPER, DR
    DALTON, AJ
    [J]. PHYSIOLOGY & BEHAVIOR, 1973, 10 (05) : 925 - 933
  • [8] Davies I, 1986, Rev Environ Health, V6, P251
  • [9] SPINAL-FLUID ALUMINUM LEVELS IN PATIENTS WITH ALZHEIMER-DISEASE
    DELANEY, JF
    [J]. ANNALS OF NEUROLOGY, 1979, 5 (06) : 580 - 581
  • [10] ESIRI MM, 1984, J NEUROL NEUROSUR PS, V47, P57